Brilacidin, a novel antifungal agent against Cryptococcus neoformans is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2021/04977-5
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2022/08796-8
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2021/10599-3
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2022/13603-4
NIAID NIH HHS
Grant: R01 AI153356
NIAID NIH HHS
Grant: R21 AI178330
NIAID NIH HHS
Grant: R01 AI053721
National Institutes of Health
Grant: 5R01AI053721-05
Comparative and functional genomics of C. neoformans
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AI153356-04
Deciphering the phenotypic and genomic traits that underlie the evolution of pathogenicity differences among Aspergillus fumigatus and its close relatives
National Institutes of Health
Grant: 1R21AI178330-01
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals